CIBC World Market’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-14,050
Closed -$359K 1230
2023
Q2
$359K Buy
+14,050
New +$333K ﹤0.01% 995
2021
Q4
Sell
-24,484
Closed -$1.16M 1355
2021
Q3
$1.16M Buy
+24,484
New +$1.14M ﹤0.01% 736
2020
Q1
Sell
-8,934
Closed -$310K 1046
2019
Q4
$310K Buy
+8,934
New +$302K ﹤0.01% 944
2019
Q2
Sell
-29,512
Closed -$989K 1157
2019
Q1
$989K Buy
+29,512
New +$929K ﹤0.01% 666
2018
Q4
Sell
-105,676
Closed -$4.06M 1123
2018
Q3
$4.06M Buy
105,676
+90,090
+578% +$3.31M 0.02% 342
2018
Q2
$547K Buy
15,586
+6,900
+79% +$241K ﹤0.01% 829
2018
Q1
$289K Buy
+8,686
New +$296K ﹤0.01% 997

Other funds holding FFTY

CIBC World Market's FFTY Position: Q3 2023 in Review

CIBC World Market sold out of CapForce IBD 50 ETF (FFTY) in Q3 2023, closing a stake of 14,050 shares — an estimated $359K sold.

CIBC World Market first reported a position in FFTY in Q1 2018 and held it in 7 quarters. The position peaked at $4.06M in Q3 2018. 40 funds tracked by Wall St. Rank hold FFTY as of Q3 2023.

  • CIBC World Market reported no remaining CapForce IBD 50 ETF position as of Q3 2023 after selling out during the quarter.
  • CIBC World Market sold 14,050 CapForce IBD 50 ETF shares in Q3 2023, an estimated $359K.
  • CIBC World Market first reported a position in CapForce IBD 50 ETF in Q1 2018 and held it in 7 quarters.
  • CIBC World Market's CapForce IBD 50 ETF position peaked at $4.06M in Q3 2018.
  • 40 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q3 2023.

Based on CIBC World Market's 13F filing for Q3 2023, filed 13 Nov 2023.